Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Audrey Claren"'
Oncologic and visual outcomes after postoperative proton therapy of localized conjunctival melanomas
Autor:
Juliette Thariat, Julia Salleron, Celia Maschi, Edouard Fevrier, Sandra Lassalle, Lauris Gastaud, Stephanie Baillif, Audrey Claren, Florent Baumard, Joel Herault, Jean Pierre Caujolle
Publikováno v:
Radiation Oncology, Vol 14, Iss 1, Pp 1-10 (2019)
Abstract Introduction conjunctival melanomas have high local relapse rates. Oncologic and visual outcomes can be improved with proton therapy and no-touch surgery. Material and methods a monocentric retrospective study of consecutive patients treated
Externí odkaz:
https://doaj.org/article/f8685d95c9f04d4fb6abed929617f071
Autor:
Jérôme Doyen, Marie-Pierre Sunyach, Fabien Almairac, Véronique Bourg, Arash O. Naghavi, Gwenaëlle Duhil de Bénazé, Audrey Claren, Laetitia Padovani, Karen Benezery, Georges Noël, Jean-Michel Hannoun-Lévi, Ferran Guedea, Jordi Giralt, Marie Vidal, Guillaume Baudin, Lucas Opitz, Line Claude, Pierre-Yves Bondiau
Publikováno v:
Frontiers in Oncology, Vol 10 (2021)
BackgroundThe conventional dose rate of radiation therapy is 0.01–0.05 Gy per second. According to preclinical studies, an increased dose rate may offer similar anti-tumoral effect while dramatically improving normal tissue protection. This study a
Externí odkaz:
https://doaj.org/article/a0828f7f5e3c439180ea3de2b8f7cc82
Author Correction: VEGFC negatively regulates the growth and aggressiveness of medulloblastoma cells
Autor:
Manon Penco-Campillo, Yannick Comoglio, Álvaro Javier Feliz Morel, Rita Hanna, Jérôme Durivault, Magalie Leloire, Bastien Mejias, Marina Pagnuzzi, Amandine Morot, Fanny Burel-Vandenbos, Matthew Selby, Daniel Williamson, Steven C. Clifford, Audrey Claren, Jérôme Doyen, Vincent Picco, Sonia Martial, Gilles Pagès
Publikováno v:
Communications Biology, Vol 3, Iss 1, Pp 1-1 (2020)
A Correction to this paper has been published: https://doi.org/10.1038/s42003-020-01502-2.
Externí odkaz:
https://doaj.org/article/ced1fd9a1ee94504bac7021a747121a7
Autor:
Gilles Pagès, Renaud Grépin, Khalid Saad Khabar, John M. Ebos, Andréas Bikfalvi, Jean-Marc Ferrero, Delphine Borchiellini, Alain Ravaud, Jean Christophe Bernhard, Marilena Lupu-Plesu, Valerie Vial, Julien Parola, Emmanuel Chamorey, Marc Ettaiche, Lindsay S. Cooley, Walid Moghrabi, Michalis Mastri, Papa Diogop Ndiaye, Audrey Claren, Damien Ambrosetti, Sandy Giuliano, Maeva Dufies
Supplementary Table S1. A, Patient characteristics included in the study (Fig. 7, A and B). B, Patient characteristics included in the study (Fig. 7, C and D).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd1dff86394c853dd50115b9ce7db640
https://doi.org/10.1158/0008-5472.22415516.v1
https://doi.org/10.1158/0008-5472.22415516.v1
Autor:
Gilles Pagès, Renaud Grépin, Khalid Saad Khabar, John M. Ebos, Andréas Bikfalvi, Jean-Marc Ferrero, Delphine Borchiellini, Alain Ravaud, Jean Christophe Bernhard, Marilena Lupu-Plesu, Valerie Vial, Julien Parola, Emmanuel Chamorey, Marc Ettaiche, Lindsay S. Cooley, Walid Moghrabi, Michalis Mastri, Papa Diogop Ndiaye, Audrey Claren, Damien Ambrosetti, Sandy Giuliano, Maeva Dufies
Supplementary Figure S7: Recapitulated schema.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c139f5887e86d5e2e2d805f60be3d0ea
https://doi.org/10.1158/0008-5472.22415519
https://doi.org/10.1158/0008-5472.22415519
Autor:
Gilles Pagès, Renaud Grépin, Khalid Saad Khabar, John M. Ebos, Andréas Bikfalvi, Jean-Marc Ferrero, Delphine Borchiellini, Alain Ravaud, Jean Christophe Bernhard, Marilena Lupu-Plesu, Valerie Vial, Julien Parola, Emmanuel Chamorey, Marc Ettaiche, Lindsay S. Cooley, Walid Moghrabi, Michalis Mastri, Papa Diogop Ndiaye, Audrey Claren, Damien Ambrosetti, Sandy Giuliano, Maeva Dufies
Sunitinib is an antiangiogenic therapy given as a first-line treatment for renal cell carcinoma (RCC). While treatment improves progression-free survival, most patients relapse. We hypothesized that patient relapse can stem from the development of a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef39c1afc1b5ebe0b2b9bdf34ee7c90a
https://doi.org/10.1158/0008-5472.c.6509306.v1
https://doi.org/10.1158/0008-5472.c.6509306.v1
Autor:
Gilles Pagès, Renaud Grépin, Khalid Saad Khabar, John M. Ebos, Andréas Bikfalvi, Jean-Marc Ferrero, Delphine Borchiellini, Alain Ravaud, Jean Christophe Bernhard, Marilena Lupu-Plesu, Valerie Vial, Julien Parola, Emmanuel Chamorey, Marc Ettaiche, Lindsay S. Cooley, Walid Moghrabi, Michalis Mastri, Papa Diogop Ndiaye, Audrey Claren, Damien Ambrosetti, Sandy Giuliano, Maeva Dufies
Legends for supplemental figures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf35b5ceb65dea288c02ea88dc6409cc
https://doi.org/10.1158/0008-5472.22415513.v1
https://doi.org/10.1158/0008-5472.22415513.v1
Author Correction: VEGFC negatively regulates the growth and aggressiveness of medulloblastoma cells
Autor:
Matthew Selby, Steven C. Clifford, Audrey Claren, Jérôme Doyen, Sonia Martial, Álvaro Javier Feliz Morel, Amandine Morot, Rita Hanna, Bastien Mejias, Yannick Comoglio, Magalie Leloire, Marina Pagnuzzi, Fanny Burel-Vandenbos, Vincent Picco, Manon Penco-Campillo, Jérôme Durivault, Gilles Pagès, Daniel Williamson
Publikováno v:
Communications Biology, Vol 3, Iss 1, Pp 1-1 (2020)
A Correction to this paper has been published: https://doi.org/10.1038/s42003-020-01502-2.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f63bee407a1c2e0a2d02ef30b0be6b11
https://doi.org/10.1038/s42003-020-01502-2
https://doi.org/10.1038/s42003-020-01502-2
Autor:
Amandine Morot, Audrey Claren, Jérôme Doyen, Fanny Burel-Vandenbos, Steven C. Clifford, Manon Penco-Campillo, Rita Hanna, Matthew Selby, Bastien Mejias, Jérôme Durivault, Álvaro Javier Feliz Morel, Gilles Pagès, Sonia Martial, Magalie Leloire, Daniel Williamson, Marina Pagnuzzi, Yannick Comoglio, Vincent Picco
Publikováno v:
Communications Biology
Communications Biology, Vol 3, Iss 1, Pp 1-14 (2020)
Communications Biology, Nature Publishing Group, 2020, 3 (1), pp.579. ⟨10.1038/s42003-020-01306-4⟩
Communications Biology, Vol 3, Iss 1, Pp 1-14 (2020)
Communications Biology, Nature Publishing Group, 2020, 3 (1), pp.579. ⟨10.1038/s42003-020-01306-4⟩
Medulloblastoma (MB), the most common brain pediatric tumor, is a pathology composed of four molecular subgroups. Despite a multimodal treatment, 30% of the patients eventually relapse, with the fatal appearance of metastases within 5 years. The majo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a86318d0cd97feb15bbb3b32f8b5869
http://europepmc.org/articles/PMC7568583
http://europepmc.org/articles/PMC7568583
Autor:
Thomas Tessonnier, Audrey Claren, Guillaume Vogin, Stéphanie Bolle, Claire Alapetite, Sylvie Bonvalot, Florence Duffaud, Juliette Thariat, Delphine Lerouge, Hamid Mammar
Publikováno v:
Bulletin du Cancer. 105:830-838
Sarcomas are a common type of tumor within the pediatric population. The utilization of proton therapy as a primary attribute the ability to spare adjacent healthy tissue, therefore, proton therapy has become a preferential indication in pediatrics c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4f36a24095ce239cb8c2b2d19c2959d6
https://doi.org/10.1016/j.bulcan.2018.05.008
https://doi.org/10.1016/j.bulcan.2018.05.008